HUM-MOLGEN events: Cambridge Healthtech Institute's Macroresults for Microarrays

HUM-MOLGEN -> Events -> Meetings and Conferences

Cambridge Healthtech Institute's Macroresults for Microarrays

February 07, 2003

Cambridge Healthtech Institute, World Trade Center, 200 Seaport Blvd., Boston, MA 02210
May 13-14, 2003

The QUESTION: What can microarrays reliably provide and where are the greatest needs for improvement?
It depends upon whom you ask. While pharmaceutical and biotechnology researchers are divided on this question, both have a wide range of expectations for new technical developments. In terms of content, which one is best? Custom arrays, where content is defined by the user; theme arrays, where focus is centered around a disease or gene family; or whole-genome arrays, where content is defined by the species? All agree that sensitivity, high throughput, and automation are essential-but how do you best optimize format? With this "array" of possibilities comes the prerequisite of carefully assessing your specific purpose.

The ANSWER: Macroresults can be achieved with microarrays if you know the question(s) to ask. Cambridge Healthtech Institute's Fourth Annual Macroresults for Microarrays will provide practical information and results about new technical developments to help you ask the right questions and determine which array is best for your specific application.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

Expression Analysis
Dr. Jeff Brockman, Psychiatric Genomics, Inc.
Dr. Achim Fischer, Axaron Bioscience AG
Dr. Philipp Kapranov, Affymetrix, Inc.
Dr. Barry Schweitzer, Protometrix, Inc.
Dr. Sun W. Tam, Texas Biotech Corporation
Cancer Arrays
Dr. David G. Beer, University of Michigan
Dr. Michael Gieseg, Pfizer Global Research and Development
Dr. Reena Philip, MetriGenix Inc.
Dr. Michael A. Tainsky, Wayne State University
Dr. Yihong Yao, Abbott Bioresearch Center

Data Analysis
Dr. Raymond J. Cho, Ingenuity Systems, Inc.
Dr. Sorin Draghici, Wayne State University
Dr. Towia Aron Libermann, Beth Israel Deaconess Medical Center and Harvard Medical School
Dr. David Robbins, ViaLogy
Dr. William A. Schmitt, Jr., Massachusetts Institute of Technology
Dr. Joachim Theilhaber, Aventis Pharmaceuticals

Surfaces/High-Density Arrays
Dr. Diping Che, Illumina, Inc.
Dr. Peter Herzer, Amersham Biosciences
Dr. Emile F. Nuwaysir, NimbleGen Systems, Inc.
Dr. Peter Thomsen, Scandinavian Micro Biodevices A/S
Mr. Andrew C. Tolonen, Massachusetts Institute of Technology
Probes
Dr. Radoje Drmanac, Callida Genomics Inc.
Dr. Andy McShea, CombiMatrix Corporation
Dr. Niels B. Ramsing, Exiqon A/S
Dr. Timothy M. Straub, Pacific Northwest National Laboratory
Dr. Brian Ward, Sigma-Aldrich Corporation
Dr. Dong Xu, Oak Ridge National Laboratory

Hybridization/Detection
Dr. Sergei G. Bavykin, Argonne National Laboratory
Dr. Robert Getts, Genisphere Inc.
Dr. Saeed A. Khan, National Center for Toxicological Research, U.S. Food and Drug Administration
Dr. Todd Peterson, Genicon Sciences Corporation
Dr. Arnold Vainrub, University of Houston